Estradiol valerate 10 mg inj
Products billed under this code include Delestrogen, Estradiol Valerate.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Delestrogen, Estradiol Valerate.
Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Delestrogen | Endo USA, Inc. | 42023-0110-01 | 5 | $38.465 |
| Delestrogen | Endo USA, Inc. | 42023-0111-01 | 10 | $76.93 |
| Estradiol Valerate | Hikma Pharmaceuticals USA Inc. | 00143-9289-01 | 5 | $38.465 |
| Estradiol Valerate | Hikma Pharmaceuticals USA Inc. | 00143-9290-01 | 10 | $76.93 |
| Estradiol Valerate | Hikma Pharmaceuticals USA Inc. | 00143-9291-01 | 20 | $153.86 |
| Estradiol Valerate | American Regent, Inc. | 00517-0420-01 | 10 | $76.93 |
| Estradiol Valerate | American Regent, Inc. | 00517-0440-01 | 20 | $153.86 |
| Estradiol Valerate | Padagis US LLC | 00574-0870-05 | 10 | $76.93 |
| Estradiol Valerate | Padagis US LLC | 00574-0872-05 | 20 | $153.86 |
| Estradiol Valerate | Xiromed, LLC | 70700-0273-22 | 5 | $38.465 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Estradiol Valerate | Xiromed, LLC | 70700-0274-22 | 10 | $76.93 |
| Estradiol Valerate | Xiromed, LLC | 70700-0275-22 | 20 | $153.86 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $7.693 | −$0.009 | 10 MG | Estradiol valerate 10 mg inj | v1, posted September 17, 2026 |
| 3Q26 | $7.702 | +$0.513 | 10 MG | Estradiol valerate 10 mg inj | v1, posted September 15, 2026 |
| 2Q26 | $7.189 | −$0.257 | 10 MG | Estradiol valerate 10 mg inj | v1, posted September 15, 2026 |
| 1Q26 | $7.446 | +$0.198 | 10 MG | Estradiol valerate 10 mg inj | v1, posted September 15, 2026 |
| 4Q25 | $7.248 | −$0.464 | 10 MG | Estradiol valerate 10 mg inj | v1, posted September 8, 2026 |
| 3Q25 | $7.712 | +$0.411 | 10 MG | Estradiol valerate 10 mg inj | v1, posted March 10, 2026 |
| 2Q25 | $7.301 | −$0.641 | 10 MG | Estradiol valerate 10 mg inj | v1, posted March 10, 2026 |
| 1Q25 | $7.942 | +$0.437 | 10 MG | Estradiol valerate 10 mg inj | v1, posted December 19, 2025 |
| 4Q24 | $7.505 | −$0.818 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 11, 2025 |
| 3Q24 | $8.323 | −$0.333 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 11, 2025 |
| 2Q24 | $8.656 | −$0.58 | 10 MG | Estradiol valerate 10 mg inj | v1, posted March 11, 2025 |
| 1Q24 | $9.236 | −$1.386 | 10 MG | Estradiol valerate 10 mg inj | v1, posted December 19, 2024 |
| 4Q23 | $10.622 | −$0.16 | 10 MG | Estradiol valerate 10 mg inj | v1, posted October 10, 2024 |
| 3Q23 | $10.782 | +$0.733 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 5, 2024 |
| 2Q23 | $10.049 | −$1.104 | 10 MG | Estradiol valerate 10 mg inj | v1, posted February 23, 2024 |
| 1Q23 | $11.153 | +$0.794 | 10 MG | Estradiol valerate 10 mg inj | v1, posted December 6, 2023 |
| 4Q22 | $10.359 | +$0.556 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 22, 2023 |
| 3Q22 | $9.803 | −$0.292 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 9, 2023 |
| 2Q22 | $10.095 | −$0.633 | 10 MG | Estradiol valerate 10 mg inj | v1, posted December 14, 2022 |
| 1Q22 | $10.728 | −$0.54 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 8, 2022 |
| 4Q21 | $11.268 | +$0.315 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 2, 2022 |
| 3Q21 | $10.953 | +$0.74 | 10 MG | Estradiol valerate 10 mg inj | v1, posted June 2, 2022 |
| 2Q21 | $10.213 | −$1.292 | 10 MG | Estradiol valerate 10 mg inj | v1, posted March 1, 2022 |
| 1Q21 | $11.505 | – | 10 MG | Estradiol valerate 10 mg inj | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.